Clinical Study
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
Table 1
Clinical demographic data in 30 colorectal metastasis patients treated with LC Bead.
| Demographic | (%) |
| Caucasian | 24 (80%) | African American | 5 (19%) | Asian | 1 (1%) |
| Age, median (range) | 55 (40–75) |
| Gender | | Male | 19 (63%) | Female | 11 (47%) |
| Prior chemotherapy | | FOLFOX | 25 | FOLFIRI | 11 | Avastin | 27 | Xeloda | 7 | Erbitux | 3 | 5FU | 4 | Vectibex | 2 |
| Adverse Events in 57 total bead treatments | | Cholecystititis | 1 (2%) Grade 3 | Dehydration | 1 (2%) Grade 2 | Gastritis | 1 (2%) Grade 1 | Hypertension | 3 (5%) Grades 1–2 | Infection | 1 (2%) Grade 1 | Liver dysfunction/failure | 2 (4%) Grades 3,5 | Nausea | 5 (9%) Grades 1–2 | Pain | 1 (2%) Grade 1 | Vomiting | 3 (5%) Grades 1–2 |
|
|